Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

Clinical trial NCT02849626 · COMPLETED

Trial details

NCT number: NCT02849626
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Partial-Onset or Primary Generalized Tonic-Clonic Seizures

Start date: 2016-11-16
Primary completion: 2019-02-05
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.